As opioid prescribing continues to decline, more nuanced and population-specific drug trends emerge as cost drivers.
As opioid prescribing continues to decline, more nuanced and population-specific drug trends emerge as cost drivers.
Not enough time for white papers or industry reports? Check out our Clinical Minute videos!
Dr. Robert Goldberg and Sandy Shtab talk with Risk & Insurance about changing attitudes and policies around medical marijuana, its potential role in reducing reliance on opioids, and what this can mean for payers, employers, patients and PBMs.
Dr. Silvia Sacalis of Healthesystems teamed up with Dr. Adam Seidner of The Hartford for a session at NWCDC – here are 5 key takeaways.
